7:01 AM ET
8-K
Business Update
Fractyl Health Business Update
Fractyl Health is implementing a strategic reprioritization to focus on its Revita program, resulting in a 45% workforce reduction and the discontinuation of its Rejuva gene therapy program. The company expects to incur $2 million in severance charges while extending its cash runway into Q2 2027 and reducing quarterly cash burn by approximately 50%.